lansoprazole has been researched along with Addison's Anemia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attila, T | 1 |
| Santharam, R | 1 |
| Blom, D | 1 |
| Komorowski, R | 1 |
| Koch, TR | 1 |
1 other study available for lansoprazole and Addison's Anemia
| Article | Year |
|---|---|
Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anemia, Pernicious; Biopsy, Needle; Carcinoid Tumor; Female | 2005 |